As of 2024-12-05, the EV/EBITDA ratio of Infinity Pharmaceuticals Inc (INFI) is 0.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INFI's latest enterprise value is -16.29 mil USD. INFI's TTM EBITDA according to its financial statements is -41.62 mil USD. Dividing these 2 quantities gives us the above INFI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 17.2x | 16.4x |
| Forward P/E multiples | 15.7x - 21.5x | 16.1x |
| Fair Price | (19.54) - (21.54) | (20.27) |
| Upside | -43815.3% - -48286.1% | -45448.9% |
| Date | EV/EBITDA |